Orphan lysosomal solute carrier MFSD1 facilitates highly selective dipeptide transport
Proceedings of the National Academy of Sciences · 2024
DOI: 10.1073/pnas.2319686121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024. Verfasst von Danila Boytsov und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmacology, Center for Physiology and Pharmacology, Medical University of Vienna, Vienna AT-1090, Austria. Hauptthemen laut MEDLINE: Lysine, Membrane Transport Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund (FWF), Institute of Science and Technology Austria (ISTA).
Abstract (Originalsprache)
Orphan solute carrier (SLC) represents a group of membrane transporters whose exact functions and substrate specificities are not known. Elucidating the function and regulation of orphan SLC transporters is not only crucial for advancing our knowledge of cellular and molecular biology but can potentially lead to the development of new therapeutic strategies. Here, we provide evidence for the biological function of a ubiquitous orphan lysosomal SLC, the Major Facilitator Superfamily Domain-containing Protein 1 (MFSD1), which has remained phylogenetically unassigned. Targeted metabolomics revealed that dipeptides containing either lysine or arginine residues accumulate in lysosomes of cells lacking MFSD1. Whole-cell patch-clamp electrophysiological recordings of HEK293-cells expressing MFSD1 on the cell surface displayed transport affinities for positively charged dipeptides in the lower mM range, while dipeptides that carry a negative net charge were not transported. This was also true for single amino acids and tripeptides, which MFSD1 failed to transport. Our results identify MFSD1 as a highly selective lysosomal lysine/arginine/histidine-containing dipeptide exporter, which functions as a uniporter.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pharmacology, Center for Physiology and Pharmacology, Medical University of Vienna, Vienna AT-1090, Austria.
- Department of Biophysics II/Structural Biology, University of Regensburg, Regensburg DE-93053, Germany.
- Vienna BioCenter Core Facilities, Metabolomics, Vienna BioCenter, Vienna AT-1030, Austria.
- Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman JO-19328, Jordan.
- Center for Addiction Research and Science, Medical University of Vienna, Vienna AT-1090, Austria.
- Institute of Science and Technology Austria, Klosterneuburg AT-3400, Austria.
ORCID-Profile: Danila Boytsov, Gregor M Madej, Harald H Sitte, Daria Siekhaus, Walter Sandtner, Marko Roblek
Förderung
- Austrian Science Fund (FWF)
- Institute of Science and Technology Austria (ISTA)
Zitieren
APA
Boytsov, D., Madej, G. M., Horn, G., Blaha, N., Köcher, T., Sitte, H. H., Siekhaus, D., Ziegler, C., Sandtner, W., & Roblek, M. (2024). Orphan lysosomal solute carrier MFSD1 facilitates highly selective dipeptide transport. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2319686121
Vancouver
Boytsov D, Madej GM, Horn G, Blaha N, Köcher T, Sitte HH, et al. Orphan lysosomal solute carrier MFSD1 facilitates highly selective dipeptide transport. Proceedings of the National Academy of Sciences. 2024. doi:10.1073/pnas.2319686121
BibTeX
@article{Boytsov2024,
author = {Boytsov, Danila and Madej, Gregor M and Horn, Georg and Blaha, Nadine and Köcher, Thomas and Sitte, Harald H and Siekhaus, Daria and Ziegler, Christine and Sandtner, Walter and Roblek, Marko},
title = {Orphan lysosomal solute carrier MFSD1 facilitates highly selective dipeptide transport},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
doi = {10.1073/pnas.2319686121}
}
EUVIMED